{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T16:55:46Z","timestamp":1725814546498},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,28]]},"DOI":"10.7759\/cureus.12957","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T11:48:09Z","timestamp":1611834489000},"source":"Crossref","is-referenced-by-count":2,"title":["Atorvastatin-Induced Necrotizing Myopathy and its Response to Combination Therapy"],"prefix":"10.7759","author":[{"given":"Sri Harsha","family":"Boppana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan A","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Antwi-Amoabeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prahlad","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nageshwara","family":"Gullapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.13.1681","article-title":"Statin-associated myopathy","volume":"289","author":"Thompson PD","year":"2003","unstructured":"Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003, 289:1681-1690. 10.1001\/jama.289.13.1681","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s1734-1140(11)70601-6","article-title":"Statin-induced myopathies","volume":"63","author":"Tomaszewski M","year":"2011","unstructured":"Tomaszewski M, St\u0119pie\u0144 KM, Tomaszewska J, Czuczwar SJ. Statin-induced myopathies. Pharmacol Rep. 2011, 63:859-866. 10.1016\/s1734-1140(11)70601-6","journal-title":"Pharmacol Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1515161","article-title":"Statin-associated autoimmune myopathy","volume":"374","author":"Mammen AL","year":"2016","unstructured":"Mammen AL. Statin-associated autoimmune myopathy. N Engl J Med. 2016, 374:664-669. 10.1056\/NEJMra1515161","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/rhu.0000000000000497","article-title":"Statin-associated autoimmune myopathy: a systematic review of 100 cases","volume":"23","author":"Nazir S","year":"2017","unstructured":"Nazir S, Lohani S, Tachamo N, Poudel D, Donato A.  Statin-associated autoimmune myopathy: a systematic review of 100 cases. J Clin Rheumatol. 2017, 23:149-154. 10.1097\/rhu.0000000000000497","journal-title":"J Clin Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-017-6723-4","article-title":"The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): revision for clinical use, content validation, and inter-rater reliability","volume":"31","author":"Rosenson RS","year":"2017","unstructured":"Rosenson RS, Miller K, Bayliss M. The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): revision for clinical use, content validation, and inter-rater reliability. Cardiovasc Drugs Ther. 2017, 31:179-186. 10.1007\/s10557-017-6723-4","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.07.023","article-title":"Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study","volume":"15","author":"Musset L","year":"2016","unstructured":"Musset L, Allenbach Y, Benveniste O. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study. Autoimmun Rev. 2016, 15:983-993. 10.1016\/j.autrev.2016.07.023","journal-title":"Autoimmun Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000000028","article-title":"Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin","volume":"93","author":"Allenbach Y","year":"2014","unstructured":"Allenbach Y, Drouot L, Rigolet A. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine. 2014, 93:150-157. 10.1097\/md.0000000000000028","journal-title":"Medicine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0000000000000438","article-title":"Immune-mediated necrotizing myopathy associated with statins: history and recent developments","volume":"29","author":"Tiniakou E","year":"2017","unstructured":"Tiniakou E, Christopher-Stine L. Immune-mediated necrotizing myopathy associated with statins: history and recent developments. Curr Opin Rheumatol. 2017, 29:604-611. 10.1097\/bor.0000000000000438","journal-title":"Curr Opin Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.04.037","article-title":"Statin-induced anti-HMGCR-associated myopathy","volume":"68","author":"Basharat P","year":"2016","unstructured":"Basharat P, Lahouti AH, Paik JJ. Statin-induced anti-HMGCR-associated myopathy. J Am Coll Cardiol. 2016, 68:234-235. 10.1016\/j.jacc.2016.04.037","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-mediated necrotizing myopathy","volume":"20","author":"Pinal-Fernandez I","year":"2018","unstructured":"Pinal-Fernandez I, Casal-Dominguez M, Mammen AL. Immune-mediated necrotizing myopathy. Curr Rheumatol Rep. 2018, 20:21. 10.1007\/s11926-018-0732-6","journal-title":"Curr Rheumatol Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2174\/1573397114666180406101850","article-title":"Immune mediated necrotizing myopathy: where do we stand?","volume":"15","author":"Mohammed AGA","year":"2019","unstructured":"Mohammed AGA, Gcelu A, Moosajee F, Botha S, Kalla AA. Immune mediated necrotizing myopathy: where do we stand?. Curr Rheumatol Rev. 2019, 15:23-26. 10.2174\/1573397114666180406101850","journal-title":"Curr Rheumatol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8867-x","article-title":"Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure","volume":"65","author":"Shovman O","year":"2017","unstructured":"Shovman O, Gilburd B, Chayat C. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure. Immunol Res. 2017, 65:276-281. 10.1007\/s12026-016-8867-x","journal-title":"Immunol Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2017-001848","article-title":"Autoimmune necrotising myopathy and HMGCR antibodies","volume":"18","author":"Karunaratne K","year":"2018","unstructured":"Karunaratne K, Amiras D, Pickering MC, Hofer M, Viegas S. Autoimmune necrotising myopathy and HMGCR antibodies. Pract Neurol. 2018, 18:151-155. 10.1136\/practneurol-2017-001848","journal-title":"Pract Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000011858","article-title":"Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed","volume":"97","author":"Carvalho AAS","year":"2018","unstructured":"Carvalho AAS, Silva VGD, Vieira TF, Delgado PO, Corazini R, Feder D, Fonseca FLA. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed. Medicine. 2018, 97:e11858. 10.1097\/md.0000000000011858","journal-title":"Medicine"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23854","article-title":"Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies","volume":"48","author":"Mohassel P","year":"2013","unstructured":"Mohassel P, Mammen AL. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. Muscle Nerve. 2013, 48:477-483. 10.1002\/mus.23854","journal-title":"Muscle Nerve"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.81a.13158","article-title":"Identifying statin-associated autoimmune necrotizing myopathy","volume":"81","author":"Albayda J","year":"2014","unstructured":"Albayda J, Christopher-Stine L. Identifying statin-associated autoimmune necrotizing myopathy. Cleve Clin J Med. 2014, 81:736-741. 10.3949\/ccjm.81a.13158","journal-title":"Cleve Clin J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.09.005","article-title":"Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories","volume":"15","author":"Alvarado-Cardenas M","year":"2016","unstructured":"Alvarado-Cardenas M, Marin-S\u00e1nchez A, Mart\u00ednez MA. Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories. Autoimmun Rev. 2016, 15:1161-1166. 10.1016\/j.autrev.2016.09.005","journal-title":"Autoimmun Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2013.06.008","article-title":"Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins","volume":"81","author":"Lahaye C","year":"2014","unstructured":"Lahaye C, Beaufr\u00e9re AM, Boyer O, Drouot L, Soubrier M, Tournadre A. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins. Joint Bone Spine. 2014, 81:79-82. 10.1016\/j.jbspin.2013.06.008","journal-title":"Joint Bone Spine"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000096","article-title":"Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy","volume":"2","author":"Ramanathan S","year":"2015","unstructured":"Ramanathan S, Langguth D, Hardy TA. Clinical course and treatment of anti-HMGCR antibody-associated necrotizing autoimmune myopathy. Neurol Neuroimmunol Neuroinflamm. 2015, 2:96. 10.1212\/nxi.0000000000000096","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171495","article-title":"Rituximab in the treatment of refractory anti-HMGCR immune-mediated necrotizing myopathy","volume":"46","author":"Landon-Cardinal O","year":"2019","unstructured":"Landon-Cardinal O, Allenbach Y, Soulages A. Rituximab in the treatment of refractory anti-HMGCR immune-mediated necrotizing myopathy. J Rheumatol. 2019, 46:623-627. 10.3899\/jrheum.171495","journal-title":"J Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/48523-atorvastatin-induced-necrotizing-myopathy-and-its-response-to-combination-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:29Z","timestamp":1707506969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/48523-atorvastatin-induced-necrotizing-myopathy-and-its-response-to-combination-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.12957","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,28]]}}}